Talia B. Baker, MD (she/her/hers)

Chief of the Division of Transplantation and Advanced Hepatobiliary Surgery
University of Utah, United States

Disclosure information not submitted.

Presentation(s):

• 185 - First-Line Therapy Using Yttrium-90 Radioembolization Plus Systemic Gemcitabine, Cisplatin, and Capecitabine for Unresectable Intrahepatic Cholangiocarcinoma

  Monday, April 13, 2026
  4:03 PM - 4:12 PM ET